Allarity Therapeutics appoints Jesper Høiland to board, replacing Joseph Vazzano

Allarity Therapeutics, Inc.

Joseph Vazzano resigned as director effective June 30, 2025.
Jesper Høiland appointed director effective June 30, 2025; term expires at 2026 annual meeting.
Høiland joins Audit, Compensation, and Nominating & Governance Committees.
Høiland receives $50,000 annual retainer plus committee fees ($7,500/$5,000/$4,000).
Høiland had served as strategic consultant since Oct 2024; background includes Novo Nordisk and Radius Health.

item 5.02item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jesper Høiland

director

ALLR · Allarity Therapeutics, Inc.

Effective: 2025-06-30
Filed: Jun 11, 2025 23:59 UTC

On June 10, 2025, the Board appointed Mr. Jesper Høiland as a director of the Company, effective as of June 30, 2025.

Departed

Joseph W. Vazzano

director

ALLR · Allarity Therapeutics, Inc.

Effective: 2025-06-30
Filed: Jun 11, 2025 23:59 UTC

On June 5, 2025, the Board of Directors (the “ Board ”) of Allarity Therapeutics, Inc. (the “ Company ”) received the resignation of Joseph W. Vazzano as director of the Company, effective June 30, 2025.

Source: SEC EDGAR

accession 0001437749-25-020081

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.